<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="152998">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01841190</url>
  </required_header>
  <id_info>
    <org_study_id>hsd1509</org_study_id>
    <nct_id>NCT01841190</nct_id>
  </id_info>
  <brief_title>Prognostic Evaluation Of Severe Sepsis And Septic Shock. Procalcitonin Versus Delta Sofa</brief_title>
  <official_title>PROGNOSTIC EVALUATION OF SEVERE SEPSIS AND SEPTIC SHOCK. PROCALCITONIN VERSUS DELTA SOFA</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Sao Domingos</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Sao Domingos</source>
  <oversight_info>
    <authority>Brazil: National Committee of Ethics in Research</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the tendency of plasma concentration and clearance
      of procalcitonin in the first 24 and 48 hours of management of patients with severe sepsis
      and septic shock with another marker of early prognosis represented by 48 hours delta sofa.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a cohort prospective observational study that will include adult patients admitted
      to a multidisciplinary ICU of a tertiary hospital.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2012</start_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>MORTALITY</measure>
    <time_frame>28 DAYS</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">128</enrollment>
  <condition>Severe Sepsis</condition>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>PROCALCITONIN</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>DELTA SOFA</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients with severe sepsis and septic shock admitted to a multidisciplinary ICU
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients admitted to the ICU

          -  severe sepsis and septic shock

        Exclusion Criteria:

          -  Children

          -  Pregnant.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>JOSE R AZEVEDO, MD</last_name>
    <phone>55 98 32168110</phone>
    <email>jrazevedo@elo.com.br</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Sao Domingos</name>
      <address>
        <city>Sao Luis</city>
        <state>Maranhao</state>
        <zip>65060-642</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ORLANDO J TORRES, PhD</last_name>
      <phone>559832168100</phone>
      <email>o.torres@uol.com.br</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Sao Domingos</name>
      <address>
        <city>Sao Luis</city>
        <state>MA</state>
        <zip>65060-642</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JOSE R AZEVEDO, MD</last_name>
      <phone>55 98 32168110</phone>
      <email>jrazevedo@elo.com.br</email>
    </contact>
    <investigator>
      <last_name>JOSE R AZEVEDO, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <lastchanged_date>April 25, 2013</lastchanged_date>
  <firstreceived_date>April 24, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Sao Domingos</investigator_affiliation>
    <investigator_full_name>Jos√© Raimundo Araujo de Azevedo</investigator_full_name>
    <investigator_title>MD. COORDINATOR. ICU.</investigator_title>
  </responsible_party>
  <keyword>Prognosis</keyword>
  <keyword>Sepsis</keyword>
  <keyword>Septic shock</keyword>
  <keyword>Procalcitonin</keyword>
  <keyword>SOFA</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Shock</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
